Takeda and Pfizer expand Japanese arthritis alliance
This article was originally published in Scrip
Executive Summary
Pfizer and Takeda have agreed to extend their alliance for the co-promotion of Enbrel (etanercept) in Japan and have also joined forces for the promotion in this market of Pfizer's investigational rheumatoid arthritis (RA) therapy, tofacitinib.